Post-traumatic stress disorder

PharmAla releases Profitable Q1 Interim Financial Statement and Business Update

Retrieved on: 
Wednesday, January 31, 2024
PTSD, Prohibition of drugs, Research, History, Substance, CDSL, MDXX, Patient, FDA, Authorization, OTC, MDMA, Health Canada, IP, Post-traumatic stress disorder, Bank statement, Pharmaceutical industry

VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to present its Q1 Interim Financial Statement for the period ending November 30, 2023.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to present its Q1 Interim Financial Statement for the period ending November 30, 2023.
  • PharmAla showed a quarterly profit for the first time in its history, validating its low-overhead manufacturing business model.
  • PharmAla believes that this is the first quarterly profit for any publicly-traded psychedelics company.
  • PharmAla will be hosting an investor webinar on Friday the 2nd to further elaborate on its financial report as well as discuss their recent achievement of obtaining a Controlled Drugs & Substances Dealer’s License (CDSL) from Health Canada.

Red Roof® Partners with Canine Companions® Offering Traveler Savings and Helping to Transform Lives

Retrieved on: 
Thursday, February 1, 2024
Partnership, United States Army, Anxiety, Disability, The Room, Canine, Red, Room, DNA, Nightmare, Dog, American Cancer Society, Hypervigilance, Marketing, Walla, United Way, Post-traumatic stress disorder, Thurgood Marshall College, Veteran, Organization, Vaccine

Canine Companions' expertly trained service dogs make a world of difference by empowering Canine Companions' clients to lead lives with enhanced independence.

Key Points: 
  • Canine Companions' expertly trained service dogs make a world of difference by empowering Canine Companions' clients to lead lives with enhanced independence.
  • Canine Companions believes, and Red Roof agrees, that independence shouldn't be limited to those who look or live a certain way.
  • "Over the past three years, Red Roof has donated more than $100,000 to Canine Companions."
  • Canine Companions transforms the lives of people with disabilities by providing their clients with expertly trained service dogs, free of charge.

KPMG in Canada reinforces employee and community commitment to People with Disabilities

Retrieved on: 
Wednesday, January 31, 2024
PTSD, Multiple sclerosis, Disability, Research, Fear, Person, Statistics Canada, Friends, Caregiver, Spectrum, Canada Act 1982, CPA, Ageing, Rheumatoid arthritis, Diversity, KPMG, Action plan, Employment, Crohn's disease, Paralysis, Epilepsy, Accessible Canada Act, Bleeding, Post-traumatic stress disorder, Intraparenchymal hemorrhage, Culture, Workplace, Disease, CFA, Social isolation, Organization, Residential care

"The reality is, People with Disabilities still face physical, cultural, and attitudinal barriers in the Canadian workplace," says Rob Davis, Chief Inclusion, Diversity and Equity Officer, at KPMG in Canada.

Key Points: 
  • "The reality is, People with Disabilities still face physical, cultural, and attitudinal barriers in the Canadian workplace," says Rob Davis, Chief Inclusion, Diversity and Equity Officer, at KPMG in Canada.
  • As outlined in the plan, KPMG will create a Disability Inclusion Action Plan Steering Group to oversee the implementation of 40-plus actions and provide ongoing feedback.
  • People with Disabilities are an untapped pool of talent that could help Canada close the labour skills gap.
  • "Many with non-apparent disabilities hide them for fear of being stigmatized or hurting their chances of employment or promotion.

Bionomics Provides a Review of 2023 and of 2024 Plans

Retrieved on: 
Monday, January 22, 2024
MSD, Schizophrenia, BNC210, Deficit spending, Patient, Module (mathematics), PAMS, PTSD, Post-traumatic stress disorder, Sleep, Partnership, Merck & Co., GAD, NAM, Anxiety, Neuropsychiatry, SAD, Alzheimer's disease, Central nervous system, Australian Securities Exchange, FDA, DSM-IV codes, CIAS, Breakthrough therapy, Panic, Merck, Phase, Data analysis, Data, CNS, Social anxiety disorder, Pharmaceutical industry

ADELAIDE, Australia and CAMBRIDGE, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today provided a 2023 review and its outlook for 2024.

Key Points: 
  • ADELAIDE, Australia and CAMBRIDGE, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today provided a 2023 review and its outlook for 2024.
  • “Bionomics continued its evolution into a U.S.-focused, late-stage clinical company last year.
  • Voluntarily delisted from the Australian Stock Exchange in August 2023 and is currently solely listed on the NASDAQ Global Market.
  • Bionomics continues to plan the initiation of its first Phase 3 study of BNC210 in patients with SAD.

AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference

Retrieved on: 
Thursday, January 18, 2024
AEON, Clavicle, Patient, Heart rate, Research, PTSD, Post-traumatic stress disorder, AB toxin, Stellate ganglion, OLE, Neck, DSM-IV codes, Torticollis, Safety, INA, DBP, Head, Botulinum toxin, Lidocaine, IND, Ptosis, FDA, Toxicity, Rat, SGB, Acute stress disorder, Data, Week, Anatomy, Pharmaceutical industry

IRVINE, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON, AEON WS), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical conditions, today presented new clinical and pre-clinical data for ABP-450 in treating cervical dystonia (CD) and posttraumatic stress disorder (PTSD) at TOXINS 2024, a leading conference held by the International Neurotoxin Association (INA) from January 17th - 20th at the Estrel Berlin in Berlin, Germany.

Key Points: 
  • ABP-450 did not appear to increase treatment-related TEAEs at any dose in the study.
  • These results support further investigation of ABP-450 as a treatment option for patients with CD and other movement disorders.
  • “We are excited to announce positive data from the 52-week OLE portion of the Phase 2 study of ABP-450 for CD.
  • The posters presented by AEON at the TOXINS 2024 conference can be accessed on the Events and Presentations page of the Company’s corporate website.

Metro Atlanta Woman Appointed to Lead National Military Suicide Prevention Campaign

Retrieved on: 
Thursday, January 25, 2024
Post-traumatic stress disorder, Suicide, Friends, BSSC, American Red Cross, Mental health, PSAS, Firearm, Silence, COVID-19, TAPS, Organization, Marketing

ATLANTA, Jan. 25, 2024 /PRNewswire/ -- In a significant effort to combat suicide in the military community, Blue Star Families , the nation's largest nonprofit dedicated to military families, proudly announces the appointment of Kali Hoffman of Cherokee County, Georgia, as the lead of their nationwide suicide prevention campaign.

Key Points: 
  • ATLANTA, Jan. 25, 2024 /PRNewswire/ -- In a significant effort to combat suicide in the military community, Blue Star Families , the nation's largest nonprofit dedicated to military families, proudly announces the appointment of Kali Hoffman of Cherokee County, Georgia, as the lead of their nationwide suicide prevention campaign.
  • Blue Star Families appoints Kali Hoffman as the lead of their nationwide suicide prevention campaign.
  • The campaign is generously funded by the Department of Veterans Affairs' Staff Sergeant Parker Gordon Fox Suicide Prevention Grant , which propels select nonprofits to implement innovative solutions for suicide prevention and mental health assistance within the military sphere.
  • This campaign is not just about prevention; it's about creating a supportive community that understands and actively addresses the unique mental health challenges faced by our military families."

Tactical Rehabilitation, Inc. wins two Business Worldwide Magazines Corporate Excellence Awards

Retrieved on: 
Thursday, January 25, 2024
Patient, Sustainability, PTSD, Post-traumatic stress disorder, Health, Culture, TENS, CSR, Veteran, Love, 3D, Human, Chronic pain, Military personnel, Nursing, Depression

The company has now won two Business Worldwide Global Corporate Excellence Awards; Visionary Leadership in the Healthcare Business' & 'Corporate Social Responsibility (CSR) and Sustainability Champion'.

Key Points: 
  • The company has now won two Business Worldwide Global Corporate Excellence Awards; Visionary Leadership in the Healthcare Business' & 'Corporate Social Responsibility (CSR) and Sustainability Champion'.
  • In its 2023 round, the Global Corporate Excellence Awards continue to shine a spotlight on organisations and leaders who focus on relentless excellence in the business world.
  • By acknowledging these achievements on a global stage, these awards not only celebrate success but also encourage others to follow suit, fostering a culture of excellence that transcends borders and industries.
  • Over thirty years, Kevin MacRitchie has demonstrated impressive strengths in business turnaround and business structuring for rapid profitable growth.

Tactical Rehabilitation, Inc. wins two Business Worldwide Magazines Corporate Excellence Awards

Retrieved on: 
Thursday, January 25, 2024
Patient, Sustainability, PTSD, Post-traumatic stress disorder, Health, Culture, TENS, CSR, Veteran, Love, 3D, Human, Chronic pain, Military personnel, Nursing, Depression

The company has now won two Business Worldwide Global Corporate Excellence Awards; Visionary Leadership in the Healthcare Business' & 'Corporate Social Responsibility (CSR) and Sustainability Champion'.

Key Points: 
  • The company has now won two Business Worldwide Global Corporate Excellence Awards; Visionary Leadership in the Healthcare Business' & 'Corporate Social Responsibility (CSR) and Sustainability Champion'.
  • In its 2023 round, the Global Corporate Excellence Awards continue to shine a spotlight on organisations and leaders who focus on relentless excellence in the business world.
  • By acknowledging these achievements on a global stage, these awards not only celebrate success but also encourage others to follow suit, fostering a culture of excellence that transcends borders and industries.
  • Over thirty years, Kevin MacRitchie has demonstrated impressive strengths in business turnaround and business structuring for rapid profitable growth.

Sheppard Pratt Announces Dr. Matthew W. Johnson as Senior Researcher for the Center of Excellence for Psilocybin Research and Treatment

Retrieved on: 
Thursday, January 18, 2024
Psilocybin, Psychopharmacology, University, Therapy, Research, Tic disorder, MD, PTSD, DSM-IV codes, Psychotherapy, Post-traumatic stress disorder, American Psychological Association, Science, History, Pharmacology, Johns Hopkins, Economics, Psychiatry, University of Oregon, Argyreia nervosa, Experimental psychology, OCD, Safety, Publishing, Eastern Oregon University, Doctor of Philosophy, Biological psychiatry, Treatment, International Society, Depression, Pharmaceutical industry

The Center of Excellence for Psilocybin Research and Treatment is the first leading global site for the development of psychedelic therapeutics in the U.S.

Key Points: 
  • The Center of Excellence for Psilocybin Research and Treatment is the first leading global site for the development of psychedelic therapeutics in the U.S.
  • In his role as senior researcher, Dr. Johnson will join Sheppard Pratt in their efforts to integrate biological psychiatry with psychotherapy.
  • Sheppard Pratt's Center of Excellence for Psilocybin Research and Treatment brings together evidence-based innovation and the development of psychedelic therapeutics on a large scale.
  • To learn more about Sheppard Pratt's Institute for Advanced Diagnostics and Therapeutics and Center of Excellence for Psilocybin Research and Treatment, visit www.sheppardpratt.org/the-institute-for-advanced-diagnostics-and-therape... .

On Average, 15 Homeless Veterans Die on the Streets Each Day

Retrieved on: 
Thursday, January 18, 2024
Homelessness, Family, PTSD, Post-traumatic stress disorder, City, Housing, SAN, Police, Farewell, Veteran, Cremation

SAN DIEGO, Jan. 18, 2024 /PRNewswire/ -- VETCOMM, a leading provider of innovative veteran's solutions, is announcing a "Hero's Farewell" initiative providing homeless vets who pass away while living on the streets the dignified, end-of-life honors they deserve. Starting in February with the City of San Diego, CA, VETCOMM will provide cremation and farewell ceremonies to homeless veterans lacking any family claims or connections.

Key Points: 
  • Starting in February with the City of San Diego, CA, VETCOMM will provide cremation and farewell ceremonies to homeless veterans lacking any family claims or connections.
  • According to the VA, 16.3% of homeless veterans die on the streets .
  • With approximately 35,574 veterans experiencing homelessness in 2022, that number could equate to as many as 5,600 veterans dying without awareness or acknowledgement.
  • "Approximately 15 homeless die while living on the streets each day – and many are unclaimed by familial relations.